How have AVCT shares performed in 2024?

Avacta Group's stock was trading at GBX 116.50 at the start of the year. Since then, AVCT stock has decreased by 58.4% and is now trading at GBX 48.50. View the best growth stocks for 2024 here .

How were Avacta Group's earnings last quarter?

Avacta Group Plc (LON:AVCT) issued its quarterly earnings results on Monday, September, 28th. The biotechnology company reported ($3.74) EPS for the quarter. Avacta Group had a negative trailing twelve-month return on equity of 143.33% and a negative net margin of 267.00%.

What other stocks do shareholders of Avacta Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avacta Group investors own include Legal & General Group (LGEN) , SkinBioTherapeutics (SBTX) , Augean (AUG) , 7digital Group (7DIG) , American Airlines Group (AAL) , ACI Worldwide (ACIW) , Akero Therapeutics (AKRO) , Advanced Micro Devices (AMD) and Amyris (AMRS) .

How do I buy shares of Avacta Group?

Shares of AVCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:AVCT

Avacta Group (AVCT) Share Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free AVCT Stock Alerts

GBX 48.50

+0.50 (+1.04%)

(As of 04/19/2024 ET)

Compare

Today's Range: 45.50
▼
48.50
50-Day Range: 48.11
▼
100.50
52-Week Range: 46.28
▼
166.98

Volume: 2.98 million shs
Average Volume: 2.52 million shs
Market Capitalization: £170.00 million

P/E Ratio: N/A
Dividend Yield: 3.97%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Get Avacta Group alerts:

Ad WealthPress

Chances are you know the firms on this list

These are the entities that can buy MILLIONS of shares in a single day… I’m talking about huge orders that literally move the share price 1%, 2%, even 5% or more in the process. Why am I showing you that list? Well, because if you have a way to successfully detect which stocks these elite traders are likely buying in real time… All you have to do is ride the coattails of their massive orders and you can target endless trading opportunities without leaving your money exposed to the markets for too long. And in case you didn’t already know…

That’s exactly how this expert trader plans to trade his #1 ticker for 2024

About Avacta Group Stock (LON:AVCT)

Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms. The company develops AVA6000, FAPa-activated doxorubicin that is in Phase I clinical trial for treating locally advanced or metastatic-selected solid tumors; AVA3996, a tumor-targeted proteasome inhibitor based on bortezomib; AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing LR19128 PD-L1 XT; and collaboration and license agreement with Avacta and Daewoong Pharmaceutical Co. Ltd. for developing AFX-001 for solid organ transplant and graft vs host Disease, and AFX-002 for multiple sclerosis. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.

AVCT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AVCT Stock News Headlines

March 6, 2024 | finance.yahoo.com

Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024

December 19, 2023 | finanznachrichten.de

Avacta Group: Appointment of Chief Business Officer

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

December 19, 2023 | finance.yahoo.com

Appointment of Chief Business Officer

December 13, 2023 | finance.yahoo.com

ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data

October 23, 2023 | finance.yahoo.com

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

September 11, 2023 | msn.com

If I’d invested £1,000 in Avacta shares 5 years ago, here’s how much I’d have now

August 11, 2023 | lse.co.uk

Avacta Group Share Chat

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

June 21, 2023 | marketwatch.com

Avacta Completes Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

June 21, 2023 | finanznachrichten.de

Avacta Group plc: Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

June 21, 2023 | finance.yahoo.com

Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

June 19, 2023 | marketwatch.com

Avacta Group Says No Fundraising Imminent; Shares Rise

June 6, 2023 | uk.finance.yahoo.com

AVCT.L - Avacta Group Plc

April 27, 2023 | finance.yahoo.com

First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study

April 5, 2023 | finanznachrichten.de

Avacta Group plc: Avacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

March 28, 2023 | finance.yahoo.com

Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

March 16, 2023 | msn.com

Is the Avacta share price dip a buying opportunity?

January 17, 2023 | lse.co.uk

Block Listing Application to AIM

October 21, 2022 | finance.yahoo.com

Avacta Group Plc (LON:AVCT) is favoured by institutional owners who hold 58% of the company

October 1, 2022 | uk.finance.yahoo.com

Avacta Group Plc (AVCT.L)

September 5, 2022 | nasdaq.com

Avacta's AVA6000 Gets FDA Orphan Drug Designation To Treat Soft Tissue Sarcoma; Stock Up

June 30, 2022 | finance.yahoo.com

LG Chem Renews License Triggering Payment to Avacta

May 16, 2022 | benzinga.com

AffyXell Expands its Strategic Partnership With...

April 6, 2022 | proactiveinvestors.com

Avacta full-year results push shares higher

March 19, 2022 | finance.yahoo.com

Is Avacta Group (LON:AVCT) In A Good Position To Invest In Growth?

March 17, 2022 | uk.finance.yahoo.com

What’s next for the Avacta share price?

See More Headlines

Receive AVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/28/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:AVCT
CUSIP: N/A
CIK: N/A
Web: www.avacta.com
Phone: +44-1904-217070
Fax: N/A
Employees: 120
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.16)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-42,080,000.00
Net Margins: -267.00%
Pretax Margin: N/A
Return on Equity: -143.33%
Return on Assets: -26.00%

Debt

Debt-to-Equity Ratio: 225.41
Current Ratio: 0.71
Quick Ratio: 4.96

Sales & Book Value

Annual Sales: £16.02 million
Price / Sales: 10.61
Cash Flow: GBX 3.23 per share
Price / Cash Flow: 15.00
Book Value: GBX 8 per share
Price / Book: 6.06

Miscellaneous

Outstanding Shares: 350,510,000
Free Float: N/A
Market Cap: £170.00 million
Optionable: Not Optionable
Beta: 1.21

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Dr. David Alastair Maclaughlin Smith (Age 58)
CEO & Executive Director
Comp: $444k
Mr. Tony Gardiner (Age 53)
CFO, Company Secretary & Executive Director
Comp: $273k
Dr. Christina Marie Coughlin B.S. (Age 54)
M.D., Ph.D., Head of Research & Development, Interim Chief Medical Officer and Director
Comp: $37k
Ms. Emma Wright
Group In-House Counsel
Mr. Michael Vinegrad
Group Communications Director
Mr. R. Craig Slater FCA (Age 60)
Chief Operating Officer of Diagnostics
Comp: $69k
Dr. Matt Johnson
Chief Scientific Officer of Diagnostics
Dr. Fiona McLaughlin FSB (Age 54)
Ph.D., Chief Scientific Officer of Therapeutics Division
Mr. David Wilson
Chief Commercial Officer of Diagnostics
Ms. Karen Harrison
Chief Operating Officer of Therapeutics Division

Key Competitors

View All Competitors

AVCT Stock Analysis - Frequently Asked Questions

How have AVCT shares performed in 2024?: Avacta Group's stock was trading at GBX 116.50 at the start of the year. Since then, AVCT stock has decreased by 58.4% and is now trading at GBX 48.50.
View the best growth stocks for 2024 here.
How were Avacta Group's earnings last quarter?: Avacta Group Plc (LON:AVCT) issued its quarterly earnings results on Monday, September, 28th. The biotechnology company reported ($3.74) EPS for the quarter. Avacta Group had a negative trailing twelve-month return on equity of 143.33% and a negative net margin of 267.00%.
What other stocks do shareholders of Avacta Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Avacta Group investors own include Legal & General Group (LGEN), SkinBioTherapeutics (SBTX), Augean (AUG), 7digital Group (7DIG), American Airlines Group (AAL), ACI Worldwide (ACIW), Akero Therapeutics (AKRO), Advanced Micro Devices (AMD) and Amyris (AMRS).
How do I buy shares of Avacta Group?: Shares of AVCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AVCT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial